Revolutionary Trial at Griffith University: Pioneering New Treatment for Spinal Cord Injury

A groundbreaking clinical trial has started at Griffith University to test a new treatment for chronic spinal cord injuries. This is the first trial of its kind, aiming to use nasal cells to help repair damaged nerves.

The treatment focuses on olfactory ensheathing cells, which are taken from the nose. These cells play a key role in our sense of smell and are believed to help regenerate nerve pathways. Professor James St. John, who leads the research, emphasizes the potential of these cells to create a “nerve bridge.” This structure, about the size of a small worm, will be implanted at the injury site in the spinal cord.

Patients will undergo a rigorous rehabilitation program, both before and after the cell implant. The aim is to measure improvements in everyday functions, like bladder and bowel control, finger movement, and even mobility to interact with loved ones. ”Regaining independence can transform lives,” says Professor St. John.

The trial will take place at Gold Coast University Hospital and is designed to ensure safety while also assessing the potential for functional improvements. Previous animal studies have shown promise, but this is the first step to see if the treatment can help humans.

Peter Johnstone, CEO of the Clem Jones Foundation, highlights the importance of enduring support for such innovative research. With commitment from various funding sources, including state and federal bodies, the project can move forward. “[Medical research] never happens overnight,” he notes, stressing that sustained funding is crucial for long-term success.

Perry Cross, founder of the Perry Cross Spinal Research Foundation, also sees this as a pivotal moment. After becoming a quadriplegic from a rugby accident at 19, he has dedicated his life to advocating for better treatments. “This trial brings hope,” he says. “For too long, recovery seemed impossible. Now, it feels within reach.”

The concerted effort behind this trial is notable. Funders include the Medical Research Future Fund, the Queensland Government, and private donors who have all come together to support this innovative approach.

As we await the results, it’s clear that this trial represents more than just a medical study. It’s a beacon of hope for many living with spinal cord injuries, illustrating how science and compassion can work hand in hand to change lives.



Source link

Clinical Trial, Spinal Cord Injury, Biomedicine, Cell, Chronic, Efficacy, Medical Research, Microscope, Nerve, Research